MUC16 and ovarian cancer: Higher levels of CA125 and IL-10 in the serum of patients with ovarian cancer compared to patients with ovarian cysts might indicate that the combination of these biomarkers could be used for distinguishing patients with ovarian cancer from those with benign cysts.